Skip to content
logo transparent png
  • Home
  • About
    • About
    • Meet the Team
      • Scott Brinks, Owner and Chief Consultant
      • Sarah Boblenz , Senior Consultant
  • Blog & News
  • Services
    • Affordable Pricing
    • Customer Service
    • DEA Compliance Training
    • DEA Outreach
    • Enterprise Solutions
    • Interpreting Complex DEA Rules
    • Litigation & DEA Expert Witness Services
    • Inspections and Audits
    • Policy Review
    • Rapid DEA Compliance Response
    • DEA Regulatory Interpretation
    • Standard Operating Procedures
  • How to?
    • How To Register/Renew a DEA Registration
    • How to Verify a DEA Number
  • Content
Search
Newsletter
Newsletter
logo transparent png
  • Home
  • About
    • About
    • Meet the Team
      • Scott Brinks, Owner and Chief Consultant
      • Sarah Boblenz , Senior Consultant
  • Blog & News
  • Services
    • Affordable Pricing
    • Customer Service
    • DEA Compliance Training
    • DEA Outreach
    • Enterprise Solutions
    • Interpreting Complex DEA Rules
    • Litigation & DEA Expert Witness Services
    • Inspections and Audits
    • Policy Review
    • Rapid DEA Compliance Response
    • DEA Regulatory Interpretation
    • Standard Operating Procedures
  • How to?
    • How To Register/Renew a DEA Registration
    • How to Verify a DEA Number
  • Content
Newsletter Signup
Newsletter Signup

DEA News, Information, and Events

Brinks DEA Consulting delivers the latest updates and insights in DEA compliance and regulatory news.

May 14, 2026

DEA QUOTAS FOR CONTROLLED SUBSTANCES – HOW DEA CHANGED THE PROCESS FOR AMERICA’S DRUG MANUFACTURERS

Overview of DEA Quotas Within the Framework of the Controlled Substances Act The Controlled Substances Act (CSA) has been a key part of Federal law for more than 55 years. ...

April 30, 2026

Will Ibogaine Be the New Trend in Psychedelic Therapy?

The psychedelic drug ibogaine has been in the news recently. Many news articles and podcasts have brought to light ibogaine’s potential use in the treatment of anxiety, depression, traumatic brain...

April 29, 2026

When DEA Guidance Became Law: How EO 13891 Exposed a Hidden DEA Problem

Executive Order 13891 (EO 13891): Why It Was Issued and Why It Still Matters For many years, federal agencies have relied heavily on documents known as “guidance.” These guidance documents...

April 20, 2026

Patient-Owned Controlled Substances: A Hidden Compliance Risk for Pharmacies and Hospitals

What May Pharmacies and Hospitals Do with Patient-Owned Controlled Substances? Healthcare facilities routinely encounter controlled substances that belong to patients, often when a patient is admitted to a hospital, transferred...

DISCLAIMER

We offer expert guidance on controlled substance compliance and regulatory strategy, informed by prior DEA experience but unaffiliated with the agency. We do not provide legal services; for legal advice, please consult a licensed attorney.

Get In Touch

Brinks DEA Consulting
PO Box 185
Mathias, WV 26812
216-313-8191

Copyright © 2026 Brinks DEA Consulting and Compliance | Powered by Brinks DEA Consulting and Compliance